Richter's transformation in chronic lymphocytic leukemia

Current Hematologic Malignancy Reports

Volumn 2, Issue 4, 2007, Pages 265-271

  Tsimberidou, Apostolia Maria ^a   Keating, Michael J ^b   Wierda, William G ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; FLUDARABINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; METHOTREXATE; OXALIPLATIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB; VINCRISTINE;

CELL DISRUPTION; CELL PROLIFERATION; CHROMOSOME 11Q; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; CYTOLOGY; EPSTEIN BARR VIRUS; HEMATOLOGIC DISEASE; HUMAN; KARYOTYPE; MICROSATELLITE INSTABILITY; NONHODGKIN LYMPHOMA; PROGNOSIS; RADIODIAGNOSIS; REVIEW; RICHTER SYNDROME; STEM CELL TRANSPLANTATION; TREATMENT RESPONSE; TRISOMY 12; TUMOR SUPPRESSOR GENE;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL CYCLE PROTEINS; CELL TRANSFORMATION, VIRAL; CHROMOSOME ABERRATIONS; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; EPSTEIN-BARR VIRUS INFECTIONS; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOLOGIC FACTORS; IMMUNOTHERAPY; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, NON-HODGKIN; NEOPLASM PROTEINS; PROGNOSIS; STEM CELL TRANSPLANTATION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 38349050289     PISSN: 15588211     EISSN: 1558822X     Source Type: Journal    
DOI: 10.1007/s11899-007-0036-9     Document Type: Review

References (54)

1. Richter MN: Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia. Am J Pathol 1928, 4:285-292.
2. Tsimberidou AM, Keating MJ: Richter syndrome: biology, incidence, and therapeutic strategies. Cancer 2005, 103:216-228.
3. US Cancer Statistics Working Group: United States cancer statistics: 2001 incidence and mortality. Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute. 2001. Accessed May 16, 2007.
4. Robertson LE, Pugh W, O'Brien S, et al.: Richter's syndrome: a report on 39 patients. J Clin Oncol 1993, 11:1985-1989.
5. Mauro FR, Foa R, Giannarelli D, et al.: Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases. Blood 1999, 94:448-454.
6. Tsimberidou AM, O'Brien S, Khouri I, et al.: Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation. J Clin Oncol 2006, 24:2343-2351. Largest single-institution retrospective analysis. It demonstrated that patients with Richter's syndrome benefit from chemotherapy and rituximab combination therapy, and that patients with available donors should be considered for allogeneic stem cell transplantation as postremission therapy. The first prognostic score for patients with RS is proposed.
7. Miyamura K, Osada H, Yamauchi T, et al.: Single clonal origin of neoplastic B-cells with different immunoglobulin light chains in a patient with Richter's syndrome. Cancer 1990, 66:140-144.
8. Matolcsy A, Inghirami G, Knowles DM: Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma). Blood 1994, 83:1363-1372.
9. Matolcsy A: High-grade transformation of low-grade non-Hodgkin's lymphomas: mechanisms of tumor progression. Leuk Lymphoma 1999, 34:251-259.
10. Dierlamm J, Michaux L, Criel A, et al.: Genetic abnormalities in chronic lymphocytic leukemia and their clinical and prognostic implications. Cancer Genet Cytogenet 1997, 94:27-35.
11. Brynes RK, McCourty A, Sun NC, et al.: Trisomy 12 in Richter's transformation of chronic lymphocytic leukemia. Am J Clin Pathol 1995, 104:199-203.
12. Cobo F, Martinez A, Pinyol M, et al.: Multiple cell cycle regulator alterations in Richter's transformation of chronic lymphocytic leukemia. Leukemia 2002, 16:1028-1034.
13. Fulop Z, Csernus B, Timar B, et al.: Microsatellite instability and hMLH1 promoter hypermethylation in Richter's transformation of chronic lymphocytic leukemia. Leukemia 2003, 17:411-415.
14. Lee JN, Giles F, Huh YO, et al.: Molecular differences between small and large cells in patients with chronic lymphocytic leukemia. Eur J Haematol 2003, 71:235-242.
15. Ichikawa A, Hotta T, Takagi N, et al.: Mutations of p53 gene and their relation to disease progression in B-cell lymphoma. Blood 1992, 79:2701-2707.
16. Pinyol M, Cobo F, Bea S, et al.: p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood 1998, 91:2977-2984.
17. Arranz E, Martinez B, Richart A, et al.: Increased C-MYC oncogene copy number detected with combined modified comparative genomic hybridization and FISH analysis in a Richter syndrome case with complex karyotype. Cancer Genet Cytogenet 1998, 106:80-83.
18. Golay J, Luppi M, Songia S, et al.: Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias. Blood 1996, 87:1900-1911.
19. Gratama JW, Ernberg I: Molecular epidemiology of Epstein-Barr virus infection. Adv Cancer Res 1995, 67:197-255.
20. Tosato G, Blaese RM: Epstein-Barr virus infection and immunoregulation in man. Adv Immunol 1985, 37:99-149.
21. Hislop AD, Taylor GS, Sauce D, et al.: Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol 2007, 25:587-617.
22. Foon KA, Thiruvengadam R, Saven A, et al.: Genetic relatedness of lymphoid malignancies. Transformation of chronic lymphocytic leukemia as a model. Ann Intern Med 1993, 119:63-73.
23. Riddler SA, Breinig MC, McKnight JL: Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood 1994, 84:972-984.
24. Ansell SM, Li CY, Lloyd RV, et al.: Epstein-Barr virus infection in Richter's transformation. Am J Hematol 1999, 60:99-104.
25. Tsimberidou AM, O'Brien S, Kantarjian HM, et al.: Hodgkin transformation of chronic lymphocytic leukemia: the M. D. Anderson Cancer Center experience. Cancer 2006, 107:1294-1302.
26. Momose H, Jaffe ES, Shin SS, et al.: Chronic lymphocytic leukemia/small lymphocytic lymphoma with Reed-Sternberg-like cells and possible transformation to Hodgkin's disease. Mediation by Epstein-Barr virus. Am J Surg Pathol 1992, 16:859-867.
27. Tsimberidou AM, Wierda WG, O'Brien S, et al.: Combination of oxaliplatin, fludarabine, cytarabine, and rituximab in Richter's syndrome and fludarabine-refractory chronic lymphocytic leukemia [abstract]. Blood 2006, 108:799a (Abstract 2825).
28. Tsimberidou AM, Keating MJ, Bueso-Ramos CE, et al.: Epstein-Barr virus in patients with chronic lymphocytic leukemia: a pilot study. Leuk Lymphoma 2006, 47:827-836.
29. Harousseau JL, Flandrin G, Tricot G, et al.: Malignant lymphoma supervening in chronic lymphocytic leukemia and related disorders. Richter's syndrome: a study of 25 cases. Cancer 1981, 48:1302-1308.
30. Foucar K, Rydell RE: Richter's syndrome in chronic lymphocytic leukemia. Cancer 1980, 46:118-134.
31. Trump DL, Mann RB, Phelps R, et al.: Richter's syndrome: diffuse histiocytic lymphoma in patients with chronic lymphocytic leukemia. A report of five cases and review of the literature. Am J Med 1980, 68:539-548.
32. Long JC, Aisenberg AC: Richter's syndrome. A terminal complication of chronic lymphocytic leukemia with distinct clinicopathologic features. Am J Clin Pathol 1975, 63:786-795.
33. Sun T, Susin M, Desner M, et al.: The clonal origin of two cell populations in Richter's syndrome. Hum Pathol 1990, 21:722-728.
34. Pugh WC, Manning JT, Butler JJ: Paraimmunoblastic variant of small lymphocytic lymphoma/leukemia. Am J Surg Pathol 1988, 12:907-917.
35. Bayliss KM, Kueck BD, Hanson CA, et al.: Richter's syndrome presenting as primary central nervous system lymphoma. Transformation of an identical clone. Am J Clin Pathol 1990, 93:117-123.
36. Matolcsy A, Schattner EJ, Knowles DM, et al.: Clonal evolution of B cells in transformation from low- to high-grade lymphoma. Eur J Immunol 1999, 29:1253-1264.
37. van Dongen JJ, Hooijkaas H, Michiels JJ, et al.: Richter's syndrome with different immunoglobulin light chains and different heavy chain gene rearrangements. Blood 1984, 64:571-575.
38. Parrens M, Sawan B, Dubus P, et al.: Primary digestive Richter's syndrome. Mod Pathol 2001, 14:452-457.
39. Cordone I, Matutes E, Catovsky D: Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukemia: correlation with disease activity. Leukemia 1992, 6:902-906.
40. Brecher M, Banks PM: Hodgkin's disease variant of Richter's syndrome. Report of eight cases. Am J Clin Pathol 1990, 93:333-339.
41. Ohno T, Smir BN, Weisenburger DD, et al.: Origin of the Hodgkin/Reed-Sternberg cells in chronic lymphocytic leukemia with "Hodgkin's transformation." Blood 1998, 91:1757-1761.
42. Partyka S, O'Brien S, Podoloff D, et al.: The usefulness of high dose (7-10mci) gallium (67Ga) scanning to diagnose Richter's transformation. Leuk Lymphoma 1999, 36:151-155.
43. Cobo F, Rosinol L, Martinez A, et al.: Limitations of gallium-67 SPECT in histological transformation of chronic lymphocytic leukaemia: an analysis of 13 patients with clinically suspected Richter's syndrome. Br J Haematol 2002, 119:484-487.
44. Bruzzi JF, Macapinlac H, Tsimberidou AM, et al.: Detection of Richter's transformation of chronic lymphocytic leukemia by PET/CT. J Nucl Med 2006, 47:1267-1273. This is the first study to demonstrate the specificity and sensitivity of PET/CT in detecting Richter's transformation.
45. Tsimberidou AM, O'Brien SM, Cortes JE, et al.: Phase II study of fludarabine, cytarabine (Ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disorders. Leuk Lymphoma 2002, 43:767-772.
46. Dabaja BS, O'Brien SM, Kantarjian HM, et al.: Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoXome), and dexamethasone (hyperCVXD) regimen in Richter's syndrome. Leuk Lymphoma 2001, 42:329-337.
47. Tsimberidou AM, Kantarjian HM, Cortes J, et al.: Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia. Cancer 2003, 97:1711-1720.
48. Wang YF, Curtis JE, Lipton J, et al.: Cytosine arabinoside (ara-C) and cis-dichlorodiammineplatinum II (cisplatin) alone and in combination: effects on acute mycloblastic leukemia blast cells in culture and in vivo. Leukemia 1991, 5:522-527.
49. Rodriguez J, Keating MJ, O'Brien S, et al.: Allogeneic haematopoietic transplantation for Richter's syndrome. Br J Haematol 2000, 110:897-899.
50. Khouri IF, Lee MS, Saliba RM, et al.: Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival. Exp Hematol 2004, 32:28-35.
51. Tsimberidou AM, Murray JL, O'Brien S, et al.: Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in Richter syndrome. Cancer 2004, 100:2195-2200.
52. Morrison VA, Rai KR, Peterson BL, et al.: Transformation to Richter's syndrome or prolymphocytic leukemia (PLL): an Intergroup study (CALGB 9011) [abstract]. Blood 1999, 94(suppl 1):539a.
53. Tabuteau S, Fernandez J, Garidi R, et al.: Richter's syndrome in B-CLL: report of 37 cases [abstract]. Blood 1999, 34(suppl 1):306b.
54. Rai KR, Peterson BL, Appelbaum FR, et al.: Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. N Engl J Med 2000, 343:1750-1757.